After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics
No abstract is available for this item.
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G. & Lasagna, Louis, 1991. "Cost of innovation in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 10(2), pages 107-142, July.
- Lexchin, Joel, 1990. "Drug makers and drug regulators: Too close for comfort. A study of the Canadian situation," Social Science & Medicine, Elsevier, vol. 31(11), pages 1257-1263, January.
When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:40:y:1997:i:1:p:69-80. See general information about how to correct material in RePEc.
If references are entirely missing, you can add them using this form.